Interleukins 1β and 10 expressions in the periimplant crevicular fluid from patients with untreated periimplant disease

Implant Dentistry

Volumn 22, Issue 2, 2013, Pages 143-150

  Casado, Priscila Ladeira ^a   Canullo, Luigi ^b   De Almeida Filardy, Alessandra ^c   Granjeiro, José Mauro ^d   Barboza, Eliane Porto ^d,e   Leite Duarte, Maria Eugenia ^f  

^a National Institute of Traumatology and Orthopedics   (Brazil)

^b Private Practice in Orthodontics   (Italy)

^c FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^e Brazilian Institute of Periodontology   (Brazil)

^f National Institute of Traumatology and Orthopedics   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; INTERLEUKIN 10; INTERLEUKIN 1BETA;

ADULT; AGED; ARTICLE; BONE REGENERATION; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; DENTAL SURGERY; FEMALE; FOLLOW UP; GINGIVA; GINGIVITIS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; PATHOLOGY; PERIIMPLANTITIS; PERIODONTAL POCKET; PERIODONTICS; PERIODONTIUM; PHENOTYPE; PHYSIOLOGY; STOMATITIS; TOOTH IMPLANT; TOOTH PLAQUE;

ADULT; AGED; BIOLOGICAL MARKERS; CHRONIC PERIODONTITIS; DENTAL IMPLANTS; DENTAL PLAQUE INDEX; DENTAL RESTORATION FAILURE; FEMALE; FOLLOW-UP STUDIES; GINGIVA; GINGIVAL CREVICULAR FLUID; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; OSSEOINTEGRATION; PERI-IMPLANTITIS; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; PHENOTYPE; STOMATITIS;

EID: 84875366916     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/ID.0b013e3182818792     Document Type: Article

References (43)

1. Ferreira SD, Silva GL, Cortelli JR, et al. Prevalence and risk variables for peri-implant disease in Brazilian subjects. J Clin Periodontol. 2006;33:929-935. (Pubitemid 44715432)
2. Ferreira SB, Jr, Figueiredo CM, Almeida AL, et al. Clinical, histological, and microbiological findings in peri-implant disease: A pilot study. Implant Dent. 2009; 18:334-344.
3. Lang NP, Kinane DF, Lindhe J, et al. Sixth European Workshop on Periodontology of the European Academy of Periodontology at the Charterhouse at Ittingen, Thurgau, Switzerland. J Clin Periodontol. 2008;35:1-2.
4. Lang NP, Wilson TG, Corbet EF. Biological complications with dental implants: Their prevention, diagnosis and treatment. Clin Oral Implants Res. 2000; 11(1 suppl):146-155.
5. Lang NP, Berglundh T. Periimplant diseases:Where are we now?dConsensus of the Seventh European Workshop on Periodontology. J Clin Periodontol. 2011; 38(1 suppl):178-181.
6. Lindhe J, Meyle J. Peri-implant diseases: Consensus Report of the Sixth European Workshop on Periodontology. J Clin Periodontol. 2008;35:282-285.
7. Offenbacher S. Periodontal diseases: Pathogenesis. Ann Periodontol. 1996;1:821-878.
8. Gemmell E, Marshall RI, Seymour GJ. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontol 2000. 1997;14:112-143. (Pubitemid 127601173)
9. Kornman KS, Crane A, Wang HY, et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol. 1997;24: 72-77. (Pubitemid 127731494)
10. Heitz-Mayfield LJ. Peri-implant diseases: Diagnosis and risk indicators. J Clin Periodontol. 2008;35:292-304.
11. Boutros SM, Michalowicz BS, Smith QT, et al. Crevicular fluid enzymes from endosseous dental implants and natural teeth. Int J Oral Maxillofac Implants. 1996;11:322-330. (Pubitemid 126700685)
12. Salcetti JM, Moriarty JD, Cooper LF, et al. The clinical, microbial, and host response characteristics of the failing implant. Int J Oral Maxillofal Implants. 1997;12:32-42. (Pubitemid 127500370)
13. Cox SW, Eley BM. Cathepsin B/L-, elastase-, tryptase-, trypsin-and dipeptidyl peptidase IV-like activities in gingival crevicular fluid. A comparison of levels before and after basic periodontal treatment of chronic periodontitis patients. J Clin Periodontol. 1992;19: 333-339.
14. Matsuki Y, Yamamoto T, Hara K. Localization of interleukin-1 (IL-1) mRNAexpressing macrophages in human inflamed gingiva and IL-1 activity in gingival crevicular fluid. J Periodontal Res. 1993; 28:35-42.
15. Perozini C, Chibebe PC, Leao MV, et al. Gingival crevicular fluid biochemical markers in periodontal disease: a crosssectional study. Quintessence Int. 2010; 41:877-883.
16. Buchmann R, Hasilik A, Van Dyke TE, et al. Amplified crevicular leukocyte activity in aggressive periodontal disease. J Dent Res. 2002;81:716-721.
17. Toker H, Marakoglu I, Poyraz O. Effect of meloxicam on gingival crevicular fluid IL-1beta and IL1 receptor antagonist levels in subjects with chronic periodontitis, and its effects on clinical parameters. Clin Oral Invest. 2006;10:305-310. (Pubitemid 44835042)
18. Rawlinson A, Dalati MH, Rahman S, et al. Interleukin-1 and IL-1 receptor antagonist in gingival crevicular fluid. J Clin Periodontol. 2000;27:738-743.
19. Ejeil AL, Gaultier F, Igondjo-Tchen S, et al. Are cytokines linked to collagen breakdown during periodontal disease progression? J Periodontol. 2003;74: 196-201. (Pubitemid 36322274)
20. Faizuddin M, Bharathi SH, Rohini NV. Estimation of interleukin-1beta levels in the gingival crevicular fluid in health and in inflammatory periodontal disease. J Periodontal Res. 2003;38:111-114. (Pubitemid 37485607)
21. Hannocks MJ, Oliver L, Gabrilove JL, et al. Regulation of proteolytic activity in human bone marrow stromal cells by basic fibroblast growth factor, interleukin-1, and transforming growth factor beta. Blood. 1992;79:1178-1184.
22. Yin L, Li L, Pan Y, et al. [IL-1 beta mRNA and TNF-alpha mRNA expression in gingival tissues of patients with adult periodontitis]. Hua Xi Kou Qiang Yi Xue Za Zhi. 2001;19:318-321.
23. Kornman KS. Host modulation as a therapeutic strategy in the treatment of periodontal disease. Clin Infect Dis. 1999; 28:520-526. (Pubitemid 29242526)
24. Scarel-Caminaga RM, Trevilatto PC, Souza AP, et al. Interleukin 10 gene promoter polymorphisms are associated with chronic periodontitis. J Clin Periodontol. 2004;31:443-448. (Pubitemid 38765145)
25. Moheng P, Feryn JM. Clinical and biologic factors related to oral implant failure: A 2-year follow-up study. Implant Dent. 2005;14:281-288. (Pubitemid 41454443)
26. Soskolne WA. Subgingival delivery of therapeutic agents in the treatment of peridontal diseases. Critic Rev Oral Biol Med. 1997;8:164-174. (Pubitemid 27217167)
27. Misch CE, Perel ML, Wang HL, et al. Implant success, survival, and failure: the International Congress of Oral Implantologists (ICOI) Pisa Consensus Conference. Implant Dent. 2008;17:5-15.
28. Kao RT, Pasquinelli K. Thick vs thin gingival tissue: a key determinant in tissue response to disease and restorative treatment. J Calif Dent Assoc. 2002;30: 521-526.
29. Jovanovic AS. The management of peri-implant breakdown around functioning osseointegrated dental implants. J Periodontol. 1993;84:1176-1183.
30. Jung ER, Pjetursson BE, Glauser R, et al. A systemic review of the 5-year survival and complication rates of implantsupported single crowns. Clin Oral Implants Res. 2008;19:119-130.
31. Renvert S, Lindahl C, Rutger Persson G. The incidence of peri-implantitis for two different implant systems over a period of thirteen years. J Clin Periodontol. 2012;39:1191-1197.
32. Albrektsson T, Isidor F. Consensus report of session IV. In: Lang NP, Karring T, eds. Proceedings of the First European Workshop on Periodontology. London: Quintessence;1993:365-369.
33. Zitzmann NU, Berglundh T. Definition and prevalence of peri-implant diseases. J Clin Periodontol. 2008;35:286-291.
34. De Boever AL, De Boever JA. Early colonization of non-submerged dental implants in patients with a history of advanced aggressive periodontitis. Clin Oral Implants Res. 2006;17:8-17. (Pubitemid 43424595)
35. Casado PL, Otazu IB, Balduino A, et al. Identification of periodontal pathogens in healthy periimplant sites. Implant Dent. 2011;20:226-235.
36. Leonhardt A, Adolfsson B, Lekholm U, et al. A longitudinal microbiological study on osseointegrated titanium implants in partially edentulous patients. Clin Oral Implants Res. 1993; 4:113-120.
37. Hultin M, Gustafsson A, Hallstrom H, et al. Microbiological findings and host response in patients with peri-implantitis. Clin Oral Implants Res. 2002;13:349-358. (Pubitemid 41719948)
38. Aboyoussef H, Carter C, Jandinski JJ, et al. Detection of prostaglandin E2 and matrix metalloproteinases in implant crevicular fluid. Int J Oral Maxillofac Implants. 1998;13:689-696. (Pubitemid 128505862)
39. Moore KW, O'Garra A, deWaalMR, et al. Interleukin-10. Annu Rev Immunol. 1993;11:165-190. (Pubitemid 23115005)
40. Schierano G, Bellone G, Cassarino E, et al. Transforming growth factor-beta and interleukin 10 in oral implant sites in humans. J Dent Res. 2003;82:428-432. (Pubitemid 41766006)
41. Liskmann S, Vihalemm T, Salum O, et al. Correlations between clinical parameters and interleukin-6 and interleukin-10 levels in saliva from totally edentulous patients with peri-implant disease. Int J Oral Maxillofac Implants. 2006;21: 543-550. (Pubitemid 44358676)
42. Duarte PM, de mendonça AC, Máximo MB, et al.Differential cytokine expressions affect the severity of periimplant disease. Clin Oral Implants Res. 2009;20:514-520.
43. Ekfeldt A, Christiansson U, Eriksson T, et al. A retrospective analysis of factors associated with multiple implant failures in maxillae. Clin Oral Implants Res. 2001;12:462-467. (Pubitemid 33723182)